Corporate insider profile
Paul L Berns Insider Trades
Paul L Berns has reported 3 open-market purchases on SEC Form 4 and is a net buyer of $62,999,992 across 3 companies. The most recent open-market transaction was reported on Nov 4, 2026. Source: SEC Form 4 filings.
Latest reported as Corporate insider of Lyell Immunopharma, Inc. (LYEL).
SEC-reported filing activity is provided for research purposes and is not investment advice.
- Purchase filings
- 3
- Reported companies
- 3
- Net open-market value
- $62,999,992
- Latest transaction
- Nov 4, 2026
Affiliated corporations
Reported company relationships
Transaction history
Open-market Transactions
Common questions
Paul L Berns insider trading FAQ
- Is Paul L Berns buying or selling stock?
- Across all SEC Form 4 open-market filings on record, Paul L Berns is a net buyer of $62,999,992, with 3 open-market purchases reported. The latest transaction was reported on Nov 4, 2026.
- Which companies does Paul L Berns report insider trades for?
- Paul L Berns has reported open-market trades in Lyell Immunopharma, Inc. (LYEL), Aspen Neuroscience, Inc. (ASPE), Kardigan, Inc. (KARD). The latest SEC-reported relationship is Corporate insider of Lyell Immunopharma, Inc. (LYEL).
- Where does Paul L Berns's insider trading data come from?
- Watch Insiders reads the SEC Form 4 filings submitted to EDGAR under reporting owner CIK 1202769, and refreshes this page daily.
